The antibiotics we are using--especially the preventative ones--are for the most part class IV ionophores that have little or no human health relationship. So do we want to just reduce the amount of the ones that don't have a human connection, or are we more interested in finding out what the real issues are in terms of it, and taking a smart approach to making sure we reduce them?
On March 8th, 2011. See this statement in context.